BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
-22.56%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
AUM
$805M
AUM Growth
+$805M
Cap. Flow
+$128M
Cap. Flow %
15.86%
Top 10 Hldgs %
80.9%
Holding
29
New
5
Increased
6
Reduced
4
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ONC
1
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$126M 15.6% 900,000 +270,000 +43% +$37.9M
SLDB icon
2
Solid Biosciences
SLDB
$427M
$93.8M 11.58% 3,498,272 +616,672 +21% +$16.5M
PTCT icon
3
PTC Therapeutics
PTCT
$3.92B
$74M 9.14% 2,155,000
WVE icon
4
Wave Life Sciences
WVE
$1.53B
$69.4M 8.57% 1,650,000 +59,400 +4% +$2.5M
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$66.4M 8.21% 1,565,560
ICPT
6
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$60.5M 7.47% +600,000 New +$60.5M
ESPR icon
7
Esperion Therapeutics
ESPR
$448M
$55.2M 6.82% 1,200,000 -175,000 -13% -$8.05M
ODT
8
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$41.9M 5.18% 2,978,762 +151,824 +5% +$2.14M
QURE icon
9
uniQure
QURE
$896M
$34.6M 4.27% +1,200,000 New +$34.6M
RCKT icon
10
Rocket Pharmaceuticals
RCKT
$354M
$29.1M 3.6% 1,966,051
DBVT
11
DBV Technologies
DBVT
$264M
$28.9M 3.57% 4,500,000 +3,000,000 +200% +$19.3M
GBT
12
DELISTED
Global Blood Therapeutics, Inc.
GBT
$28.7M 3.55% +700,000 New +$28.7M
AMRN
13
Amarin Corp
AMRN
$311M
$20.4M 2.52% 1,500,000 +200,000 +15% +$2.72M
CBAY
14
DELISTED
Cymabay Therapeutics
CBAY
$16.5M 2.04% 2,094,000
IMMU
15
DELISTED
Immunomedics Inc
IMMU
$16.4M 2.03% +1,150,000 New +$16.4M
KURA icon
16
Kura Oncology
KURA
$686M
$11.9M 1.47% 844,789
KNSA icon
17
Kiniksa Pharmaceuticals
KNSA
$2.48B
$8.16M 1.01% 290,577 -882,123 -75% -$24.8M
MEIP icon
18
MEI Pharma
MEIP
$160M
$7.69M 0.95% 2,913,091
MDCO
19
DELISTED
Medicines Co
MDCO
$4.44M 0.55% 232,000 -1,168,000 -83% -$22.4M
KALV icon
20
KalVista Pharmaceuticals
KALV
$678M
$3.95M 0.49% 200,000
MTNB icon
21
Matinas BioPharma
MTNB
$10.1M
$3.36M 0.41% +5,642,858 New +$3.36M
RETA
22
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.81M 0.35% 50,000 -350,000 -88% -$19.6M
ELDN icon
23
Eledon Pharmaceuticals
ELDN
$155M
$519K 0.06% 324,383
VIRX
24
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-2,125,000 Closed -$4.25M
BLPH
25
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
-1,482,143 Closed -$1.6M